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bstract
The multifunctional US3 protein kinase is conserved among alphaherpesviruses. Like the herpes simplex virus US3 protein kinase, the pseu-
orabies virus (PRV) US3 protein confers resistance against apoptosis. In the current report, we introduced a point mutation in the putative ATP
inding site of the PRV US3 protein kinase. We found that, in contrast to the wild type PRV US3, the point-mutated PRV US3 does not protect
ells from apoptosis induced by PRV infection or staurosporine treatment. In addition, we found that the presence of wild type PRV US3, but not
f the point-mutated PRV US3, results in phosphorylation of the pro-apoptotic Bad protein in PRV-infected ST and HEp-2 cells. In PRV-infected
T cells, but not in HEp-2 cells, an additional, US3- and phosphorylation-independent alteration of Bad could be observed. These results suggest
hat the kinase activity of the US3 protein of PRV is crucial to protect cells from apoptotic cell death during infection, at least partly by leading to
hosphorylation of the pro-apoptotic Bad protein.
2007 Elsevier B.V. All rights reserved.
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. Introduction
Alphaherpesviruses comprise a closely related subfamily
f the herpesviruses that cause relatively mild, but some-
imes devastating disease, including encephalitis. The viral US3
erine/threonine protein kinase is conserved among alphaher-
esviruses and is a multifunctional protein. The US3 kinase
rthologues of herpes simplex virus (HSV) and, recently, of
he porcine pseudorabies virus (PRV), have been shown to sup-
ress apoptosis induced by alphaherpesvirus infection or by
xternal stimuli (e.g. Leopardi et al., 1997; Ogg et al., 2004;
eenen et al., 2005). The US3 kinases of HSV type 1 (HSV-
), PRV and Marek’s disease virus have been demonstrated to
e implicated in viral egress from the nucleus (Wagenaar et al.,
995; Klupp et al., 2001; Reynolds et al., 2002; Schumacher
t al., 2005). Recently, we and others have shown that the US3
inase of different alphaherpesviruses induces alterations in the
∗ Corresponding author. Tel.: +32 9 264 73 74; fax: +32 9 264 74 95.
E-mail address: Herman.Favoreel@UGent.be (H.W. Favoreel).
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oi:10.1016/j.virusres.2007.04.006ctin cytoskeleton. These actin rearrangements consist of the
isassembly of actin stress fibers (Murata et al., 2000; Van
innebruggen et al., 2003; Schumacher et al., 2005), and the
ormation of long, branched cellular projections (Calton et al.,
004; Favoreel et al., 2005), and are associated with enhanced
ntercellular virus transmission (Favoreel et al., 2005). Fur-
hermore, the US3 kinase has been reported to be involved in
ownregulating the major histocompatibility complex class I
MHC I) expression in varicella-zoster virus (VZV)-infected
ells (Abendroth et al., 2001), in the HSV-induced inactiva-
ion of cytotoxic T-lymphocytes (CTLs) (Sloan et al., 2003) and
n the reduced sensitivity of HSV-1 and VZV-infected cells to
nterferon (Piroozmand et al., 2004; Schaap et al., 2005).
How US3 exerts its different functions is far from fully under-
tood. Since the US3 protein possesses serine/threonine kinase
ctivity, an important first step to understand the mechanism
f US3-induced effects, is to analyze whether they rely on the
inase activity of the protein. Kinase activity has recently been
hown to be important for the function of US3 during nuclear
gress, since a point-mutated, kinase-impaired US3 protein of
SV-1 was found to be unable to complement the reduced
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fficiency in virus egress from the nucleus of a US3null virus
Ryckman and Roller, 2004). Kinase activity of HSV-1 US3
as also been found to be important for suppressing apopto-
is induced by overexpression of pro-apoptotic Bcl-2 family
embers (Ogg et al., 2004). Whether kinase activity of US3
s equally important for protecting cells from apoptosis dur-
ng alphaherpesvirus infection or during apoptosis induction by
ther exogenous stimuli is not known.
In the current report, we investigated whether mutation of a
onserved lysine residue in the putative ATP binding domain of
S3 had an effect on its anti-apoptotic properties during infec-
ion or treatment with staurosporine. We report that this mutation
ndeed disrupts the ability of PRV US3 to protect cells from
poptosis. In addition, we show that intact kinase activity of PRV
S3 results in phosphorylation of the pro-apoptotic Bad protein
uring PRV infection and that other, US3- and phosphorylation-
ndependent and cell type-specific Bad alterations may occur in
RV-infected cells.
. Methods
.1. Construction of point-mutated US3
Construction was done, essentially as described before
or HSV US3, by the introduction of a point mutation in
conserved lysine residue that is critical for ATP binding
Ryckman and Roller, 2004). Mutation consisted of a sub-
titution of lysine 136 in the PRV US3 ORF by glutamine
nd was introduced by PCR using pfx polymerase. Primers
o introduce the mutation were US3mutF (ACGGTGGTGCT-
CAGGTGGGCCAGA) and US3mutR (reverse complement
f US3mutF). In a first step, the point-mutated 5′ region of US3
as generated and PCR amplified from a plasmid containing
he entire US3 ORF under control of the CMV promotor (pKG1,
eenen et al., 2005) using a T7 primer (Invitrogen) (T7 promoter
s located 5′ of US3 in pKG1) and US3mutR. The point-mutated
′ region of US3 was generated and PCR amplified from pKG1
sing US3mutF and a BGH primer (Invitrogen, Groningen, The
etherlands) (BGH promoter is located 3′ of US3 in pKG1).
n a second step, the entire point-mutated US3 ORF was gen-
rated and PCR amplified using T7 and BGH primers, using a
ixture of both former PCR products as targets. The resulting
CR product was checked for the presence of the mutation and
he absence of other mutations by restriction digestion (mutation
ntroduces an extra PstI site) and sequencing. The point-mutated
S3 ORF was digested with HindIII and NotI, and the result-
ng 1366 bp fragment, containing the entire point-mutated US3
RF, was cloned in a HindIII-NotI-digested pKG1 backbone,
esulting in pHF61.
.2. Viruses, cells and reagents
Swine testicle (ST) cells were used and cultured as described
efore (Geenen et al., 2005). Human laryngeal epidermoid car-
inoma HEp-2 cells were cultured in Eagle’s minimal essential
edium (MEM) with 10% foetal calf serum (FCS), 100 U/ml
enicillin, 0.1 mg/ml streptomycin, 0.3 mg/ml glutamine and
d
H
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× MEM non-essential amino acids. Wild type and isogenic
S3null PRV NIA-3 viruses were used. The latter has been
escribed and characterized earlier and is an NIA3 wild type
erived mutant that was constructed by insertion of a palin-
romic 20-mer oligonucleotide, containing TAG translational
top codons in all reading frames, in the 5′ part of the US3
pen reading frame (ORF). Insertion of this oligonucleotide
n any protein-encoding gene, in any orientation and in any
eading frame results in premature translational termination
de Wind et al., 1990; van Zijl et al., 1988, 1990). Plasmid
cDNA3.1D/V5-His©/lacZ (pLacZ/V5), anti-V5 antibodies,
ITC-labeled goat anti-mouse and goat anti-rabbit antibodies,
exas red-labeled goat anti-mouse antibodies, LipofectamineTM
nd Dynabeads® Protein A were from Invitrogen (Carlsbad, Cal-
fornia, USA). US3-specific mouse monoclonal antibodies were
indly provided by LeighAnne Olsen and Lynn Enquist (Prince-
on University, USA). Rabbit antibodies directed against active
aspase-3 and human/mouse Bad were from R&D Systems Inc.
Minneapolis, MN). HRP-conjugated secondary goat anti-rabbit
nd goat anti-mouse antibodies were purchased from Dako
ytomation (Denmark), calf intestinal alkaline phosphatase
CIP) and corresponding reaction buffer from New England
ioLabs (Ipswich, MA) and both Hybond-P PVDF membrane
nd enhanced chemiluminescence (ECL) reagents from Amer-
ham Biosciences (GE Healthcare, Buckinghamshire, UK).
taurosporine, BSA and both rabbit anti-actin and mouse
nti-phospothreonine antibodies were from Sigma Chemical
ompany (St. Louis, Missouri). Hydrogen peroxide and citric
cid were purchased from VWR International Inc. (San Diego,
alifornia, USA).
.3. Transfections
Plasmids pKG1, pHF61 or control plasmid pLacZ were tran-
iently transfected in cells grown to 60–70% confluency using
ipofectamineTM according to the manufacturer’s instructions
Invitrogen), and used at 24 h post-transfection.
.4. Apoptosis assays
Apoptosis was induced by infection of cells with US3null
RV (m.o.i. of 10) for 24 h or by the addition of 1.5M stau-
osporine for 12 h, followed by immunofluorescent detection
f the presence of active caspase-3 (using caspase-3-specific
abbit antibodies and FITC-labeled goat anti-rabbit antibod-
es) and US3 (using US3-specific mouse antibodies and Texas
ed-labeled goat anti-mouse antibodies), and analysis by fluores-
ence and confocal microscopy, all as described before (Geenen
t al., 2005).
.5. Detection of Bad phosphorylation and actin (loading
ontrol)Phosphorylation of Bad was assessed, essentially as
escribed before (Cartier et al., 2003). In brief, both ST and
Ep-2 cells were either not transfected or transfected with
KG1 or pHF61. At 24 h post-transfection, cells were either
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ock-infected or infected with WT PRV or US3null PRV. All
nfections were done at an m.o.i. of 10 and in a total vol-
me of 1 ml culture medium. At 24 h post-inoculation, cells
ere collected on ice using a rubber policeman, washed in
NE buffer (50 mM Tris, 150 mM NaCl, 1 mM EDTA, pH 6.8)
nd lysed in TNE lysis buffer (TNE with 1% Triton-X 100,
mM Na3VO4, 10 mM NaF, protease inhibitor cocktail) for
h at 4 ◦C. Cell lysates were fractionated on a 15% polyacry-
amide gel by SDS–PAGE and then transferred to a Hybond-P
VDF membrane. After blotting, the membranes were blocked
n 5% non-fat dry milk in 0.1% PBS/Tween-20 for 1 h at room
emperature (RT), and incubated with affinity purified rabbit
nti-human/mouse Bad overnight at 4 ◦C. Following incuba-
ion with HRP-conjugated secondary goat anti-rabbit antibodies,
lots were developed by ECL. After development, blots were
ashed and incubated with rabbit anti-actin. Following incuba-
ion with HRP-conjugated secondary goat anti-rabbit antibodies,
second ECL was performed. All incubation steps were done
n blocking buffer.
.6. Detection of threonine-phosphorylated proteins and
ctin (loading control)
The same ST cell lysates as mentioned in Section 2.5 were
oaded on a 12% polyacrylamide gel. After Western blotting,
he blot was blocked in 5% BSA in 0.2% TBS/Tween-20 for 1 h
t RT, and then washed overnight. Following incubation with
ouse anti-phosphothreonine and HRP-conjugated secondary
oat anti-mouse antibodies, the blot was developed by ECL. All
ncubation steps were done in blocking buffer. After develop-
ent, the blot was washed and then treated with 15% hydrogen
eroxide during 30 min at RT to remove the remaining HRP
ignal. Finally, actin was detected as described in Section 2.5.
.7. In vitro phosphatase treatment
ST cells were either mock-infected or infected with WT PRV
t an m.o.i. of 10 in a total volume of 1 ml culture medium.
t 24 h post-inoculation, cells were collected and washed as
escribed in Section 2.5. Following cell lysis in TNE lysis buffer
s described in 2.5 but without phosphatase inhibitors, Bad was
mmunoprecipitated using Dynabeads® Protein A according to
he manufacturer’s instructions (Invitrogen). Before elution, the
ead–antibody–Bad complexes were treated with either 0 or 10
nits CIP for 1 h at 37 ◦C. Finally, immunoprecipitated Bad was
luted in 0.1 M citrate pH 3.1 and 2× SDS–PAGE loading buffer
as added. SDS–PAGE, Western blotting and Bad detection
ere performed as described in Section 2.5.
.8. Detection of US3 expression levels in transfected cells
ST cells were either not transfected or transfected with pKG1
r pHF61. At 24 h post-transfection, cells were harvested by
rypsinisation and washed in PBS. Cells were fixed in 3%
araformaldehyde for 10 min at RT, followed by permeabi-
ization using 0.1% Triton-X 100 for 2 min at RT. Both the
rimary and secondary incubation, using mouse anti-US3 and
c
o
Uarch 128 (2007) 65–70 67
ITC-conjugated goat anti-mouse antibodies, respectively, were
erformed at 37 ◦C for 1 h. All antibody dilutions were made in
BS. Finally, fluorescence intensity of the cells was analyzed by
ow cytometry (FACSCanto, Beckton-Dickinson Biosciences,
an Jose, California), analyzing 10,000 cells.
. Results
.1. Construction of a eukaryotic expression vector
ncoding a PRV US3 protein containing a point mutation in
ts putative ATP binding domain
The US3 protein kinase of PRV exists as two isoforms, a long
nd a short isoform, with the long isoform only differing from
he short isoform by the presence of an N-terminal mitochondrial
ocalisation signal (Van Minnebruggen et al., 2003; Calton et al.,
004). Interestingly, the long isoform, although the less abun-
ant isoform in infected cells, appears to contain the strongest
apacity to suppress apoptosis (Geenen et al., 2005).
A eukaryotic expression vector encoding the long isoform of
RV US3 (pKG1) was used as a template to create the mutated
ariant of US3. A plasmid derived from pKG1 and encod-
ng a kinase-impaired recombinant PRV US3 protein (pHF61)
as constructed, principally as done before for HSV-1 US3
Ryckman and Roller, 2004), by point mutation of a conserved
ysine residue in the US3 ORF that is critical for ATP binding
Leung-Tack et al., 1994; Ryckman and Roller, 2004). Cor-
ect mutagenesis was checked by restriction enzyme digestion
additional PstI site) and by sequencing.
Using flow cytometry, we confirmed that both wild type
nd point-mutated US3 show similar protein expression levels
Fig. 1).
.2. Intact kinase activity of PRV US3 is necessary for
xerting its anti-apoptotic effects
Earlier, we have found that PRV US3, like its HSV-1 ortho-
ogue, is able to suppress apoptosis induced by virus infection
r staurosporine (Leopardi et al., 1997; Geenen et al., 2005).
To investigate a possible involvement of the kinase activity
f US3 in apoptosis induced by an alphaherpesvirus infection
r staurosporine addition, ST cells were transiently transfected
ith either pLacZ (a control plasmid), pKG1 (encoding wild
ype US3), or pHF61 (encoding point-mutated US3), and, at
4 h post-transfection, subjected to apoptosis-inducing stimuli:
nfection with US3null PRV (Fig. 2A) or addition of 1.5M
tauroporine (Fig. 2B). Transfected cells were subsequently ana-
yzed for the activation of caspase-3. Both Fig. 2A and B show
elative percentages of apoptosis, compared to the percentage
f apoptosis observed in cells transfected with the control plas-
id and infected with US3null PRV (Fig. 2A) or treated with
taurosporine (Fig. 2B), which were set to 100%. Absolute per-
entages of apoptosis observed in cells transfected with the
ontrol plasmid and subsequently infected with US3null PRV
r treated with staurosporine were approximately 30–40%.
Infection of lacZ-transfected cells with wild type instead of
S3null PRV led to a decrease in the relative percentage of
68 M. Deruelle et al. / Virus Research 128 (2007) 65–70
Fig. 1. Wild type (B) and point-mutated US3 (C) show similar protein expression levels. ST cells were either not transfected (A) or transfected with pKG1 (B)
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ITC-conjugated goat anti-mouse antibodies, fluorescence intensity of the cel
-axis fluorescence intensity. The latter corresponds with US3 protein expressio
poptotic cells from 100 to 68.6 ± 4.1%. Similarly, transfection
ith wild type US3 instead of lacZ and subsequent infection
ith US3null PRV led to a decrease in the relative percentage
f apoptotic cells from 100 to 56.3 ± 3.1%, all in agreement
ith earlier observations (Geenen et al., 2005). In contrast, cells
ransfected with the point-mutated US3 were not able to with-
tand apoptosis induced by US3null PRV (relative percentage
f apoptosis: 100.1 ± 1.3%).
Comparable results were obtained using staurosporine to
nduce apoptosis instead of US3null PRV and are illustrated
n Fig. 2B. Again, cells transfected with wild type US3, but not
ith mutant US3, were able to suppress apoptosis.
Together, these results show that a point mutation in the puta-
ive ATP binding site of the US3 protein of PRV abolishes
ts anti-apoptotic function during infection and staurosporine
reatment.
.3. Intact kinase activity of PRV US3 results in
hosphorylation of BadFor HSV-1, it has been shown that the US3 protein kinase
hosphorylates, and thereby inactivates, the pro-apoptotic Bcl-2
amily member Bad, which may partly explain the mecha-
ism of the anti-apoptotic activity of this protein (Cartier et
l
m
U
t
ig. 2. A US3 recombinant carrying a point mutation in the putative ATP binding
r staurosporine (B). ST cells were transfected with pLacZ (control), pKG1 (wild ty
noculated with wild type or US3null PRV (A) or cells were left untreated (NT) or treat
ith anti-V5 antibodies (pLacZ) or anti-US3 antibodies (pKG1 and pHF61) and ap
iven are relative percentages compared to the number of apoptotic cells in pLacZ-tra
each set to 100%). Only the US3 or control transfected cells were considered in thelized. Following an immunofluorescence staining using mouse anti-US3 and
s analyzed by flow cytometry, analyzing 10,000 cells. X-axis shows cell size,
els.
l., 2003; Kato et al., 2005). We determined whether PRV US3
lso induces phosphorylation of the pro-apoptotic Bad. Since
t has been shown that PRV US3 displays anti-apoptotic activ-
ty in both ST (Geenen et al., 2005) and HEp-2 cells (Ogg et
l., 2004), we investigated a possible PRV US3-mediated Bad
hosphorylation in both cell types. Phosphorylation of Bad in
RV-infected HEp-2 and ST cells was assessed by detection of a
and shift in Western blot analysis, as described before (Cartier
t al., 2003).
Western blot analysis on HEp-2 (Fig. 3A) and ST cells
Fig. 3C) indeed revealed a shift of the Bad protein to a higher
likely phosphorylated – band during infection with WT PRV,
ompared to mock-infected cells. ST cells showed higher basal
evels of phosphorylated Bad than HEp-2 cells (compare band
atterns of mock-infected cells in Fig. 3A and C). Treatment
f immunoprecipitated Bad from mock- or WT PRV-infected
T and HEp-2 cells with phosphatase confirmed that the upper
ad bands represent phosphorylated Bad (Fig. 4). Infection of
T cells with wild type PRV resulted in Bad phosphorylation,
hereas infection with US3null PRV did not (Fig. 3A and C,anes 2 and 3), indicating that Bad phosphorylation is US3-
ediated. Transfection of wild type US3 prior to infection with
S3null virus restored Bad phosphorylation, whereas transfec-
ion with point-mutated US3 did not (Fig. 3A and C, lanes 4
site is unable to protect cells against apoptosis induced by US3null PRV (A)
pe US3) or pHF61 (point-mutated US3). At 24 h post-transfection, cells were
ed with 1.5M staurosporine (B). Afterwards, transfected cells were visualised
optotic cells were visualised by anti-active caspase-3 antibodies. Percentages
nsfected cells infected with US3null PRV (A) or treated with staurosporine (B)
calculations. Data represent mean ± S.D. of three independent assays.
M. Deruelle et al. / Virus Rese
Fig. 3. Intact kinase activity of PRV US3 results in phosphorylation of the
pro-apoptotic Bad protein in PRV-infected cells. WT PRV US3 induces Bad
phosphorylation in PRV-infected HEp-2 (A and B) and ST-cells (C–E). ST and
HEp-2 cells were either not transfected (lanes 1–3) or transfected with wild
type (pKG1; lane 4) or mutant US3 (pHF61; lane 5). Twenty-four hours later,
cells were either mock-infected (lane 1), or infected with WT PRV (lane 2) or
US3null PRV (lanes 3 to 5). At 24 h post-inoculation, cells were collected and
lysed for 1 h at 4 ◦C. Total cell lysates were separated by SDS–PAGE followed by
Western blot analysis with a Bad-specific antibody (A and C), an actin-specific
antibody (B and D), or a phosphothreonine-specific antibody (E). Phosphory-
lated and unphosphorylated Bad in A and C are indicated by arrows. Panels B
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end D represent the actin loading controls. Panel E shows that the lack of Bad
hosphorylation in the US3null PRV-infected cells is not due to a general lack
f serine/threonine phosphorylation in these cells.
nd 5). Thus, intact kinase activity of PRV US3 results in phos-
horylation of Bad in PRV-infected cells. These data indicate
hat phosphorylation, and thereby inactivation, of Bad may be
f importance in explaining the anti-apoptotic effect of US3.
n addition, for each condition the total amount of threonine-
ig. 4. Phosphatase treatment of immunoprecipitated Bad from mock- and WT
RV-infected ST (upper panel) and HEp-2 (lower panel) cells confirms that
he upper Bad band represents phosphorylated Bad. Moreover, in PRV-infected
T cells, but not in HEp-2 cells, an additional, US3- and phosphorylation-
ndependent alteration of Bad could be observed. At 24 h post-inoculation, both
ock and WT PRV-infected ST and HEp-2 cells were collected. Following cell
ysis, Bad was immunoprecipitated and then treated with either 0 or 10 units
IP for 1 h at 37 ◦C. Finally, immunoprecipitated Bad was eluted in 0.1 M cit-
ate pH 3.1 and samples were separated by SDS–PAGE, followed by Western
lot analysis using a Bad-specific polyclonal antibody.
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hosphorylated proteins was visualised on the ST blot, which
onfirmed that the lack of Bad phosphorylation in the US3null
RV-infected cells is not due to a general lack of serine/threonine
hosphorylation in these cells (Fig. 3E). Proteins are indeed
hosphorylated to similar levels, regardless whether cells are
nfected with wild type or US3null PRV, or whether cells are
ransfected with wild type or mutant US3 prior to US3null PRV
nfection, although, as expected, the phosphorylation pattern in
nfected cells differs from that in mock-infected cells (Fig. 3E).
Curiously, Bad migrated slower in WT and US3null PRV-
nfected ST cells compared to mock-infected ST cells, which
as not observed in HEp-2 cells (Figs. 3A and C and 4). Interest-
ngly, the slower migration was not phosphorylation-mediated,
ince phosphatase treatment did not shift the lower band in PRV-
nfected ST cells down to the level of the lower Bad band in
ock-infected cells (Fig. 4). This indicates that there are US3-
nd phoshorylation-independent alterations in Bad mobility in
RV-infected ST cells but not in HEp-2 cells.
. Discussion
In the current report, we show that a point mutation in the
utative ATP binding site of the PRV US3 kinase destroys the
nti-apoptotic activity of this protein during PRV infection and
taurosporine treatment. In addition, we found that the intact, but
ot the mutated, US3 protein of PRV results in phosphorylation
f the pro-apoptotic protein Bad in PRV-infected ST and HEp-
cells. Moreover, we found that in PRV-infected ST cells, but
ot in HEp-2 cells, an additional, US3- and phosphorylation-
ndependent alteration of Bad occurs.
Our finding that a kinase-intact PRV US3 results in phospho-
ylation of the pro-apoptotic protein Bad in PRV-infected cells is
n line with reports on the potential anti-apoptotic effect of HSV-
US3, which has been reported to phosphorylate Bad (Cartier
t al., 2003; Kato et al., 2005). These data indicate that phospho-
ylation, and thereby inactivation, of Bad may be of importance
n explaining the anti-apoptotic effect of US3. This may also
t in our earlier observation that the mitochondria-located long
soform of US3 shows more pronounced anti-apoptotic activity
han the short isoform that does not migrate to mitochondria
Geenen et al., 2005). For the cellular protein kinase A, it has
een shown before that its mitochondrial localisation is of cru-
ial importance for efficient phosphorylation of Bad, thereby
reventing apoptosis (Harada et al., 1999). Of particular interest
n this context is that HSV-1 US3 has been reported to func-
ionally overlap protein kinase A to prevent apoptosis (Benetti
nd Roizman, 2004) and has very recently been shown to co-
ractionate with mitochondria (Poon et al., 2006). However, it is
mportant to also point out that it has been shown for HSV-1 that
S3 still displays anti-apoptotic activity in cells that express a
utant form of Bad that cannot be phosphorylated on the reg-
latory serines at positions 112, 136, and 155, indicating that
S3 may contain additional anti-apoptotic activities, other than
ad phosphorylation at these specific sites (Benetti et al., 2003;
gg et al., 2004).
We also noticed that US3null PRV-infected cells express-
ng wild type US3 in trans show a somewhat better protection
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gainst apoptosis than wild type PRV-infected cells (US3 in
is) (Fig. 2), which confirms our earlier findings (Geenen et
l., 2005). This is probably due to the higher expression levels
f US3 in transfected cells than in infected cells, leading to a
etter protection against apoptosis. Interestingly, we observed a
S3- and phosphorylation-independent shift in Bad mobility in
estern blot in PRV-infected ST cells, which was not present
n PRV-infected HEp-2 cells (Figs. 3A and C and 4). Further
xperiments will be needed to determine whether this cell type-
ependent alteration in Bad mobility reflects a species-specific
ifference in PRV-mediated Bad alteration, which viral proteins
ay be involved, and what the consequences may be for virus
eplication and apoptotic cell death.
In conclusion, we found that a point mutation in the puta-
ive ATP binding site of PRV US3 disrupts the ability of
his protein to protect cells from apoptosis during infection
nd staurosporine treatment and prevents Bad phoshorylation
n PRV-infected ST and HEp-2 cells, and that additional,
ell type-dependent and US3- and phosphorylation-independent
lterations in Bad may occur in PRV-infected cells.
cknowledgments
The authors would like to thank LeighAnne Olsen and Lynn
nquist (Princeton University, USA) for US3-specific antibod-
es, the ID-DLO (Lelystad, the Netherlands) for NIA-3 PRV
trains, and Nele Dennequin, Carine Boonen, Lieve Sys and
hantal Vanmaercke for excellent technical assistance. This
esearch was supported by a cooperative research action fund of
he Research Council of Ghent University and a research grant
rom the Research Foundation-Flanders (FWO-Vlaanderen),
rant nr. G.0196.06.
eferences
bendroth, A., Lin, I., Slobedman, B., Ploegh, H., Arvin, A.M., 2001. Varicella-
Zoster virus retains major histocompatibility complex class I proteins in the
golgi compartment of infected cells. J. Virol. 75, 4878–4888.
enetti, L., Munger, J., Roizman, B., 2003. The herpes simplex virus 1 US3
protein kinase blocks caspase-dependent double cleavage and activation of
the proapoptotic protein Bad. J. Virol. 77, 6567–6573.
enetti, L., Roizman B,., 2004. Herpes simplex virus protein kinase US3 acti-
vates and functionally overlaps protein kinase A to block apoptosis. Proc.
Natl. Acad. Sci. U.S.A. 101, 9411–9416.
alton, C.M., Randall, J.A., Adkins, M.W., Banfield, B.W., 2004. The pseu-
dorabies virus serine/threonine kinase Us3 contains mitochondrial, nuclear
and membrane localization signals. Virus Genes 29, 131–145.
artier, A., Komai, T., Masucci, M.G., 2003. The Us3 protein kinase of herpes
simplex virus 1 blocks apoptosis and induces phosporylation of the Bcl-2
family member Bad. Exp. Cell. Res. 291, 242–250.
e Wind, N., Zijderveld, A., Glazenburg, K., Gielkens, A., Berns, A., 1990.
Linker insertion mutagenesis of herpesviruses: inactivation of single genes
within the Us region of pseudorabies virus. J. Virol. 64, 4691–4696.avoreel, H.W., Van Minnebruggen, G., Adriaensen, D., Nauwynck, H.J., 2005.
Cytoskeletal rearrangements and cell extensions induced by the US3 kinase
of an alphaherpesvirus are associated with enhanced spread. Proc. Natl.
Acad. Sci. U.S.A., Published June 10th, 2005 on the PNAS Early Edition
website (e-pub ahead of print).
Warch 128 (2007) 65–70
eenen, K., Favoreel, H.W., Olsen, L., Enquist, L.W., Nauwynck, H.J., 2005.
The pseudorabies virus US3 protein kinase possesses anti-apoptotic activity
that protects cells from apoptosis during infection and after treatment with
sorbitol or staurosporine. Virology 331, 144–150.
arada, H., Becknell, B., Wilm, M., Mann, M., Huang, L.J., Taylor, S.S., Scott,
J.D., Korsmeyer, S.J., 1999. Phosphorylation and inactivation of BAD by
mitochondria-anchored protein kinase A. Mol. Cell. 3, 413–422.
ato, A., Yamamoto, M., Ohno, T., Kodaira, H., Nishiyama, Y., Kawaguchi, Y.,
2005. Identification of proteins phosphorylated directly by the Us3 protein
kinase encoded by herpes simplex virus 1. J. Virol. 79, 9325–9331.
lupp, B.G., Granzow, H., Mettenleiter, T.C., 2001. Effect of the pseudorabies
virus US3 protein on nuclear membrane localization of the UL34 protein
and virus egress from the nucleus. J. Gen. Virol. 82, 2363–2371.
eopardi, R., Van Sant, C., Roizman, B., 1997. The herpes simplex virus 1
protein kinase US3 is required for protection from apoptosis induced by the
virus. Proc. Natl. Acad. Sci. U.S.A. 94, 7891–7896.
eung-Tack, P., Audonnet, J.C., Riviere, M., 1994. The complete DNA sequence
and the genetic organization of the short unique region (US) of the bovine
herpesvirus type 1 (ST strain). Virology 199, 409–421.
urata, T., Goshima, F., Daikoku, T., Takakuwa, H., Nishiyama, Y., 2000.
Expression of herpes simplex virus type 2 US3 affects the Cdc42/Rac
pathway and attenuates c-Jun N-terminal kinase activation. Genes Cells 5,
1017–1027.
gg, P.D., McDonell, P.J., Ryckman, B.J., Knudson, C.M., Roller, R.J., 2004.
The HSV-1 Us3 protein kinase is sufficient to block apoptosis induced
by overexpression of a variety of Bcl-2 family members. Virology 319,
212–224.
iroozmand, A., Koyama, A.H., Shimada, Y., Fujita, M., Arakawa, T., Adachi,
A., 2004. Role of Us3 gene of herpes simplex virus type 1 for resistance to
interferon. Int. J. Mol. Med. 14, 641–645.
oon, A.P., Benetti, L., Roizman, B., 2006. U(S)3 and U(S)3.5 protein kinases
of herpes simplex virus 1 differ with respect to their functions in block-
ing apoptosis and in virion maturation and egress. J. Virol. 80, 3752–
3764.
eynolds, A.E., Wills, E.G., Roller, R.J., Ryckman, B.J., Baines, J.D., 2002.
Ultrastructural localization of the herpes simplex virus type 1 UL31, UL34,
and US3 proteins suggests specific roles in primary envelopment and egress
of nucleocapsids. J. Virol. 76, 8939–8952.
yckman, B.J., Roller, R.J., 2004. Herpes simplex virus type 1 primary envelop-
ment: UL34 protein modification and the US3-UL34 catalytic relationship.
J. Virol. 78, 399–412.
chaap, A., Fortin, J., Sommer, M., Zerboni, L., Stamatis, S., Ku, C., Nolan,
G.P., Arvin, A.M., 2005. T-Cell tropism and the role of ORF66 protein in
pathogenesis of varicella-zoster virus infection. J. Virol. 79, 12921–12933.
chumacher, D., Tischer, B.K., Trapp, S., Osterrieder, N., 2005. The protein
encoded by the US3 orthologue of Marek’s disease virus is required for
efficient de-envelopment of perinuclear virions and involved in actin stress
fiber breakdown. J. Virol. 79, 3987–3997.
loan, D.D., Zahariadis, G., Posavad, C.M., Pate, N.T., Kussick, S.J., Jerome,
K.R., 2003. CTL are inactivated by herpes simplex virus-infected cells
expressing a viral protein kinase. J. Immunol. 171, 6733–6741.
an Minnebruggen, G., Favoreel, H.W., Jacobs, L., Nauwynck, H.J., 2003. Pseu-
dorabies virus US3 protein kinase mediates actin stress fiber breakdown. J.
Virol. 77, 9074–9080.
an Zijl, M., Quint, W., Briaire, J., De Rover, T., Gielkens, A., Berns, A.,
1988. Regeneration of herpesviruses from molecularly cloned subgenomic
fragments. J. Virol. 62, 2191–2195.
an Zijl, M., van der Gulden, H., de Wind, N., Gielkens, A., Berns, A., 1990.
Identification of two genes in the unique short region of pseudorabies virus:Virol. 71, 1747–1755.
agenaar, F., Pol, J.M., Peeters, B., Gielkens, A.L., de Wind, N., Kimman,
T.G., 1995. The US3-encoded protein kinase from pseudorabies virus affects
egress of virions from the nucleus. J. Gen. Virol. 76, 1851–1859.
